Abstract:Objective:To investigate relationships of expression levels of EGFR,p-EGFR and p-IGFR-1β in colorectal cancer cell lines with their sensitivities to gefitinib,and assess relationships of the expression in specimen tissues with clinicopathological parameters of colorectal cancer patients.Methods:The levels of EGFR,p-EGFR and p-IGFR-1β expression were determined with western blot analysis after gross protein was extracted.Band gray scale scan was performed to evaluate the relative value of protein expression.Results:EGFR or p-EGFR was expressed highest in Lovo cells,lowest in SW620 cells(P0.05),and no differences among the other cell lines.p-IGFR-1β was undetectable or expressed at very low levels in the most and moderate gefitinib-sensitive cell lines(Lovo,HT29 and SW480) and was seemingly much lower in the most sensitive cell line(Lovo) than in the moderate ones(HT29 and SW480) and however,expressed at strikingly high levels in all resistant cell lines(HCT116,LS174T and SW620).55.6%(10/18) colorectal cancer specimens had higher levels of EGFR expression than 37.5%(3/18) did in normal tissue specimens from the same patients.33.3%(6/18) tumor tissue had significant higher levels of p-EGFR than 5.6%(1/18) did in normal tissue(P0.05).44.4%(8/18) tumor tissue had significant higher levels of p-IGFR-1β than 11.1%(2/18) did in normal tissue(P0.05).The expression of EGFR,p-EGFR and p-IGFR-1β had no correlation with each other.EGFR or p-EGFR expression did not show any association with the clinicopathological parameters,while p-IGFR-1β expression was significantly increased in patients with lymph node metastasis(P0.05),and there was a same trend in patients with advanced stage.Conclusion:With our previous study,it is suggested that the colorectal cancer cells were best sensitive to gefitinib,which expressed high p-EGFR and low p-IGFR-1β.The expression of p-EGFR and p-IGFR-1β were both significantly increased in colorectal cancer tissue and were independent from each other,and increased p-IGFR-1β expression may favor the metastasis of colorectal cancer.

[Association of Epithermal Growth Factor Receptor Expression and Its Downstream Gene Mutation Status with Radiosensitivity of Colorectal Carcinoma Cell Lines in Vitro].

Epidermal Growth Factor Receptor Gene Mutations in Non-Small-cell Lung Cancer Cells Are Associated with Increased Radiosensitivity in Vitro

Systemic Analysis of Different Colorectal Cancer Cell Lines and TCGA Datasets Identified IGF-1R/EGFR-PPAR-CASPASE Axis As Important Indicator for Radiotherapy Sensitivity.

[Effect of Gefitinib on Radiosensitivity of Gastric Cancer Cell Lines].

Quantitative Test of Mutant Egfr and Its Effect on Efficacy of Egfr Tki in Advanced Nsclc

Effect of EGFR Mutation on Radiation-Induced DNA Repair in Pulmonary Adenocarcinoma Cells

Relationship Between Mutations of Epidermal Growth Factor Receptor in the Plasma and Pleural Effusion and Responses to Gefitinib in Advanced Pretreated Non-Small Cell Lung Cancer

Inhibition of EGFR Nuclear Translocation Attenuate Radioresistance Through Decreased P-Dna-pk Expression in Cervical Cancer Cells.

Adaptive EGF Expression Sensitizes Pancreatic Cancer Cells to Ionizing Radiation Through Activation of the Cyclin D1/P53/PARP Pathway

The Inhibition Of Egfr Nuclear Translocation Attenuates Radioresistance Through Decreasing The Expression Of P-Dna-Pk In Cervical Cancer Cells

Relationship between the sensitivity of human colon carcinoma cells to gefitinib and the expressions of Akt and MAPK

The Regulation Effect of EGFR Signaling Pathway on PD-L1 Expression on Esophageal Squamous Cell Carcinoma Cell Lines.

Effectors of epidermal growth factor receptor pathway: the genetic profiling ofKRAS, BRAF, PIK3CA, NRAS mutations in colorectal cancer characteristics and personalized medicine.

Rad51 in regulating the radiosensitivity of non-small cell lung cancer with different epidermal growth factor receptor mutation status.

The Influence of K-Ras Mutation on Epidermal Growth Factor Receptor Inhibitor Sensitive Cell Lines

Expression and Significance of EGFR, P-Egfr and P-Igfr-1β in Human Colorectal Cancer Cell Lines and Specimen Tissues

Radiosensitization of phosphatidylinositol 3-1dnase inhibitor on esophageal cancer cell line Eca-109 and its mechanism

Association between epidermal growth factor receptor mutations and the expression of excision repair cross-complementing protein 1 and ribonucleotide reductase subunit M1 mRNA in patients with non-small cell lung cancer.

EGFR inhibitors and radiosensitivity of tumor cells

Effect of Growth Factor and Its Receptor and COX-2 Expressions to Progression and Prognosis in Colorectal Carcinoma

Differential Gene Expression Profiles of DNA Repair Genes in Esophageal Cancer Cells after X-ray Irradiation